WK93502 - Revision of E2882-19 Standard Guide for Analysis of Clandestine Drug Laboratory Evidence | ASTM

Using Artificial Intelligence (AI) on ASTM standards and related intellectual property is prohibited. Violations will result in suspension of access.

Home
FAQ

Home
FAQ

Home
Membership & Participati…

/

Technical Committees

/

WK93502 - Revision of E2…

Loading...

About ASTM

Governance Global Cooperation Corporate Citizenship History Regional Offices and Websites Diversity, Equity, Inclusion & Belonging Culture & Careers

Membership & Participation

Membership Technical Committees Member Tools Meetings, Symposia & Workshops Academic Outreach Emerging Professionals Publish with ASTM Consumer Participation

Standards & Solutions

Standards & Publications Enterprise Solutions ASTM Compass®Digital Library Market Insights & Innovation Laboratory Services Training Courses Certification Cement & Concrete Reference Lab

News

Standardization News Press Releases Podcasts Español Editorial Calendar and Media Kit

Help

Contact ASTM Locations FAQ

Policies

Privacy Policy Logo Policy IP Policy Return Policy Copyright & Permissions

Copyright © 1996 - 2025 ASTM. All Rights Reserved. ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA, 19428-2959 USA

Work Item

ASTM WK93502

Revision of E2882-19 Standard Guide for Analysis of Clandestine Drug Laboratory Evidence

Rationale

This standard is up for its five-year review.

Details

Developed by Subcommittee: E30.14

Committee: E30

Staff Manager: James Morgan

Work Item Status

Date Initiated: 01-20-2025

Technical Contact: David Gouldthorpe

Item: 006

Ballot: E30 (25-01)

Status: Will Reballot Item

Item: 012

Ballot: E30 (25-07)

Status: Negative Votes Need Resolution

Related

Copyright/Permissions